The PROSPeCT trial has completed recruitment. Many thanks to all those who made this possible. Patient follow-up is ongoing.
This prospective multicentre cohort study, funded by the National Institute for Health Research Health Technology Assessment programme was led by Professor Vicky Goh from King’s College London, and delivered by a group of BSGAR investigators.
Study objective:
PROSPeCT was designed with the following primary objective: To improve the prediction of metastatic disease in patients with colorectal cancer by developing a prognostic model based on disease free survival via prospective evaluation of both conventional predictive variables and novel variables derived from Perfusion CT.
Recruitment:
Recruitment to PROSPecT has closed with 447 patients recruited, and follow-up is ongoing.
Queries:
Questions about the PROSPeCT study should be directed to the Team at the following address:
PROSPeCT Study Co-ordinator
Cancer Clinical Trials Unit Scotland, Edinburgh
Email: [email protected]
